Effectiveness of mRNA BNT162b2 Vaccine 6 Months after Vaccination among Patients in Large Health Maintenance Organization, IsraelExpedited Published on 2022-02-012022-10-31 Journal: Emerging Infectious Diseases [Category] COVID-19, MERS, [키워드] age all age groups Analysis Booster vaccine conducted coronavirus disease Coronaviruses COVID-19 decrease determine Epidemiology greater Health Health Maintenance Organization HMO IgG IgG level immune response Infection infection rate infections initial Israel maintenance Month mRNA BNT162b2 mRNA BNT162b2 vaccine National organization PCR-confirmed PCR-positive Person public health respiratory infections risk SARS-CoV-2 serologic tests severe acute respiratory syndrome coronavirus 2 steadily decreased subsequent Support tested vaccination Vaccines viruses zoonoses [DOI] 10.3201/eid2802.211834 PMC 바로가기 [Article Type] Expedited
Persistence of Anti-SARS-CoV-2 Antibodies in Long Term Care Residents Over Seven Months After Two COVID-19 Outbreaks두 번의 COVID-19 발생 후 7개월 동안 장기 요양 시설 입소자의 항 SARS-CoV-2 항체 지속성Immunology Published on 2022-01-032022-09-11 Journal: Frontiers in Immunology [Category] MERS, 진단, 치료법, [키워드] 229E Analysis Anti-nucleocapsid antibodies anti-nucleocapsid antibody Anti-spike antibody antibody levels approved attack rate binding domain Canada Care carried changes in collected comparison COVID-19 COVID-19 outbreak cross reaction demonstrated evaluate finding Gradual HCoV HCoV-229E HCoV-HKU1 HCoV-NL63 HCoV-OC43 HKU1 human coronavirus human coronavirus (HCoV) humoral humoral immune response Humoral response humoral responses individual individuals Long long term Long term care facilities median MONITOR monitors Month multiplexed immunoassay NL63 nucleocapsid OC43 outbreak Outbreak investigation outbreak investigations Outbreaks over participant participated performed platform provided public health RBD reaction Receptor binding domain Reinfection resident SARS-CoV-2 serologic test serologic testing serologic tests serological serological survey Serological surveys seronegative seropositive seropositive individual serostatus serum serum sample serum samples Seven Spike protein Spike proteins statistical analyses statistically significant survey term the spike protein were used [DOI] 10.3389/fimmu.2021.775420 PMC 바로가기 [Article Type] Immunology
Antibody Response against SARS-CoV-2 Infection: Implications for Diagnosis, Treatment and Vaccine DevelopmentSARS-CoV-2 감염에 대한 항체 반응: 진단, 치료 및 백신 개발에 미치는 영향Review Published on 2022-01-012022-09-12 Journal: International reviews of immunology [Category] SARS, 진단, [키워드] antibody Antibody Response Characteristics convalescent plasma Convalescent plasma therapy development diagnostic Efficacy and safety humoral humoral response to COVID-19 infected patient infected patients infections information monoclonal Neutralizing neutralizing monoclonal antibodies neutralizing monoclonal antibody produced provided Quantitative reported response robust SARS-CoV-2 SARS-COV-2 infection serologic tests specific neutralizing antibody specificity therapeutic options Vaccine Vaccine design [DOI] 10.1080/08830185.2021.1929205 PMC 바로가기 [Article Type] Review
Serologic response to COVID-19 infection and/or vaccine in cancer patients on active treatment활성 치료 중인 암 환자의 COVID-19 감염 및/또는 백신에 대한 혈청학적 반응Article Published on 2021-12-012022-09-11 Journal: ESMO open [Category] SARS, 변종, 치료법, [키워드] active treatment anti-S Anti-S1 antibody antibody response rate Antibody titer biologic BNT162b2 BNT162b2 mRNA BNT162b2 mRNA COVID-19 vaccine booster Cancer cancer patient Cancer patients Chemotherapy Chemotherapy treatment Cohort control group COVID-19 COVID-19 infection COVID-19 vaccination COVID-19 vaccine COVID-19 vaccines domain dose evaluated Health care Health care worker humoral identify Immunocompromised Immunocompromised patient Immunocompromised patients immunogenic immunogenicity Immunologic immunologic response Immunotherapy Infection less metastatic disease multiple regression model natural infection Neutralizing antibody titer Odds ratio other treatment other treatments Patient positive positive response reduced response rate S1/S2 SARS-CoV-2 variant SARS-CoV-2 variants serologic Serologic response serologic test serologic tests serological surveillance shown significantly solid tumor solid tumors Specific subgroup subgroups the SARS-CoV-2 Treatment tumors vaccination Vaccine vaccine doses Virological were measured [DOI] 10.1016/j.esmoop.2021.100283 PMC 바로가기 [Article Type] Article
CAN IgG ANTIBODIES DIRECTED AGAINST DIFFERENT TARGETS SOLVE THE PROBLEM OF FALSE-POSITIVE RESULTS IN SARS-CoV-2 SEROLOGY?다른 표적에 대한 IgG 항체가 SARS-CoV-2 혈청학에서 위양성 결과의 문제를 해결할 수 있습니까?Article Published on 2021-12-012022-09-12 Journal: Acta clinica Croatica [Category] SARS, 진단, [키워드] addition Anti- SARS-CoV-2 IgG antigens cross-reactivity ELFA ELISA False-positive results France global pandemic IgG Infection Italy medium observation offer other coronavirus Patient positive Positive predictive value positive result RT-PCR assays SARS-CoV SARS-CoV 2 SARS-CoV-2 SARS-COV-2 infection serologic test serologic tests serology serology test serology testing Spread tested [DOI] 10.20471/acc.2021.60.04.25 PMC 바로가기 [Article Type] Article
Neutralizing antibody responses following natural SARS-CoV-2 infection: Dynamics and correlation with commercial serologic tests자연적인 SARS-CoV-2 감염에 따른 중화 항체 반응: 상업적 혈청학적 검사와의 역학 및 상관관계Article Published on 2021-11-012022-09-11 Journal: Journal of Clinical Virology [Category] MERS, SARS, 진단, 치료기술, 치료법, [키워드] allocation anti-SARS-CoV-2 Anti-spike Antibody Response Antibody titer Antibody titers assays booster doses correlation COVID-19 cross-reactivity demonstrated detect diagnostic domain Dynamics Efficacy Elecsy Elecsys ELISA Euroimmun evaluate evaluated except for facilitate Follow-up healthcare worker IgG immunoassay immunoassays long term MONITOR NAbs Neutralizing antibodies Neutralizing antibody response neutralizing capacity participant participated performed plaque reduction neutralization Post-vaccine Protein reference standard SARS-CoV-2 SARS-CoV-2 IgG SARS-CoV-2 immunity SARS-COV-2 infection SARS-CoV-2 neutralizing antibodies sera serologic test serologic tests seronegative seroprevalence survey significant decrease Support the immunoassay total antibodies vaccination [DOI] 10.1016/j.jcv.2021.104988 PMC 바로가기 [Article Type] Article
SARS-CoV-2 infection in general practice in Ireland: a seroprevalence studyResearch Published on 2021-08-302022-10-28 Journal: BJGP Open [Category] COVID-19, [키워드] acute respiratory syndrome antibody Antibody testing antibody tests average can be used clinics Community coronavirus COVID-19 COVID-19 disease detectable General practice healthcare help highest IgG IgG antibody immune response Immunity Immunoglobulin Infection Ireland lowest National offered participant Patient PCR PCR-confirmed POC POC testing point-of-care point-of-care systems polymerase chain positive positive PCR test Post-infection public health Result SARS-CoV-2 SARS-COV-2 infection Seroepidemiologic studies serologic tests Symptom utilised virus while [DOI] 10.3399/BJGPO.2021.0038 PMC 바로가기 [Article Type] Research
SARS-CoV-2 Infection among Medical Institution Faculty and Healthcare Workers in Tokyo, Japan일본 도쿄의 의료 기관 교수진 및 의료 종사자 중 SARS-CoV-2 감염Article Published on 2021-08-152022-09-11 Journal: Internal medicine (Tokyo, Japan) [Category] SARS, 치료기술, [키워드] 95% CI 95% confidence interval acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 analyzed antibody antibody-positive result Care Clinical characteristics coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 patient demographic and clinical characteristics detect dysgeusia dysosmia effective evaluated faculty Fever Frequency greater HCW HCWs healthcare worker Healthcare workers Immunoglobulin Immunoglobulin G Infection infection rate institution Japan material measure Medical care Mild no significant difference objective occurred participant positive positive test result precautions recruited reduce Result risk of COVID-19 SARS-CoV-2 SARS-COV-2 infection serologic test serologic tests severe acute respiratory syndrome Coronavirus significant difference Spread the SARS-CoV-2 Tokyo worker [DOI] 10.2169/internalmedicine.7033-21 PMC 바로가기 [Article Type] Article
Screening Antibodies Raised against the Spike Glycoprotein of SARS-CoV-2 to Support the Development of Rapid Antigen AssaysArticle Published on 2021-07-272022-10-27 Journal: ACS Omega [Category] COVID-19, [키워드] antibody Antigen antigens Asymptomatic case Biomarker coronavirus Coronavirus-2 country cross-reactivity detection development diagnose Diagnosis diagnostic diagnostic test diagnostic tests diagnostic value disease early stage envelope protein group identify immunoassay immunoassays include infected case Infection lateral flow leading management membrane protein molecular monoclonal antibody nucleocapsid protein promote provided Rapid Rapid diagnostic test Research resources SARS-CoV-2 SARS-CoV-2 spike protein Screening sensitivity serologic serologic tests spike glycoprotein Spike protein Support Surveillance the Spike therapeutic Transmission viral pathogen [DOI] 10.1021/acsomega.1c01321 PMC 바로가기 [Article Type] Article
Surveillance on Healthcare Workers During the First Wave of SARS-CoV-2 Pandemic in Italy: The Experience of a Tertiary Care Pediatric HospitalPublic Health Published on 2021-07-262022-10-31 Journal: Frontiers in Public Health [Category] COVID-19, MERS, SARS, [키워드] acute respiratory syndrome analyzed clinical manifestation clinical manifestations Community Contact coronavirus coronavirus disease COVID-19 Critical experience Florence handling HCW HCWs healthcare healthcare worker highest hospital identify implementation infected individual Infection limit lowest majority monitoring nasopharangeal swabs nasopharyngeal Non-COVID-19 Nurse offered pandemic patients positive professionals Real-time PCR reduce Registered risk RT-PCR SARS-C0V-2 SARS-CoV-2 serologic test serologic tests Spread Surveillance Swab symptomatic and asymptomatic Tertiary university virus spread Wave worker [DOI] 10.3389/fpubh.2021.644702 PMC 바로가기 [Article Type] Public Health